82822:HK:HK-CSOP FTSE China A50 (CNY)

ETF | Others |

Last Closing

USD 11.63

Change

-0.04 (-0.34)%

Market Cap

USD 9.12B

Volume

0.15M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.25 (-1.26%)

USD 143.27B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-0.98 (-1.34%)

USD 27.21B
2823:HK iShares FTSE A50 China

+0.04 (+0.30%)

USD 18.78B
2801:HK iShares Core MSCI China ETF

-0.35 (-1.74%)

USD 18.72B
83188:HK ChinaAMC CSI 300 Index ETF

+0.24 (+0.62%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

-0.01 (-1.01%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

-0.09 (-0.98%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

+0.01 (+0.14%)

USD 3.03B
9846:HK iShares Core CSI 300

+0.02 (+0.70%)

USD 2.96B

ETFs Containing 82822:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.36% 29% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.36% 29% F 31% F
Trailing 12 Months  
Capital Gain 17.06% 72% C 74% C
Dividend Return 3.22% 47% F 28% F
Total Return 20.28% 73% C 73% C
Trailing 5 Years  
Capital Gain -16.81% 35% F 70% C-
Dividend Return 11.16% 73% C 37% F
Total Return -5.65% 44% F 68% D+
Average Annual (5 Year Horizon)  
Capital Gain -4.23% 50% F 48% F
Dividend Return -2.03% 57% F 48% F
Total Return 2.20% 67% D+ 43% F
Risk Return Profile  
Volatility (Standard Deviation) 16.58% 59% D- 94% A
Risk Adjusted Return -12.23% 57% F 47% F
Market Capitalization 9.12B 73% C 83% B

Annual Financials (CNY)

Quarterly Financials (CNY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike